Document is current
Any future updates will be listed below
-
Authors
Wittau, Jonathan
Seifert, Roland
-
Funding
Funding for this research was provided by:
Else Kröner-Fresenius-Stiftung (Promotionsprogramm DigiStrucMed 2020_EKPK.20)
Else Kröner-Fresenius-Stiftung (Promotionsprogramm DigiStrucMed 2020_EKPK.20)
Medizinische Hochschule Hannover (MHH)
- License Information
-
More Information
Article History
Received: 25 May 2024
Accepted: 1 July 2024
First Online: 6 July 2024
Declarations
:
: This research was conducted according to the guidelines of good scientific practice of the Hannover Medical School (). The Hannover Medical School follows the guidelines of the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG).
: Not applicable.
: J.W. declares no conflict of interest. R.S. is the Editor-in-Chief of Naunyn-Schmiedebergs Arch Pharmacol. R.S. has an interest in the positive development of the journal as a location to publish true and honest science. R.S. confirms that he follows the rules pertinent for editors when acting as authors for Naunyn-Schmiedbergs Arch Pharmacol ().
